Search
for
Sort by
Research 601–630 of 1000+
- ST008 Male androgenetic alopecia: A new treatment paradigm
- E.L.F. square waves: a new therapy for androgenetic alopecia?
- E.L.F. sqare waves: a new therapy for androgenetic alopecia?
- Ethosomes: New Prospects in Transdermal Delivery
- A New Look at the 5?-Reductase Inhibitor Finasteride
- A new classification of pattern hair loss that is universal for men and women: Basic and specific (BASP) classification
- A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix
- A new mutation Rim3 resembling Re den is mapped close to retinoic acid receptor alpha (Rara) gene on mouse Chromosome 11
- A new catalyst for organic synthesis: mercuric triflate
- A new path in defining light parameters for hair growth: Discovery and modulation of photoreceptors in human hair follicle
- A New Primary Wound Dressing Made of Polyethylene Oxide Gel
- Two New Unrelated Cases of Hereditary 1,25-Dihydroxyvitamin D-resistant Rickets with Alopecia resulting from the same Novel Nonsense Mutation in the Vitamin D Receptor Gene
- Organotypic culture of outer root sheath cells from human hair follicles using a new culture device
- Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5
- A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
- A new case of Ambras syndrome associated with a paracentric inversion (8) (q12; q22)
- A new hair follicle-derived human epidermal model for the evaluation of sunscreen genoprotection
- A New Case of Isolated Trichothiodystrophy
- A New Humanized Mouse Model for Alopecia Areata
- A new spectrophotometric method for the determination of finasteride in tablets
- A New Classification of Male Pattern Baldness and a Clinical Study of the Anterior Hairline
- Opening new horizons in regenerative dermatology using platelet‐based autologous therapies
- Development of a new gas chromatography–mass spectrometry (GC–MS) methodology for the evaluation of 5α-reductase activity
- A new mutation resulting in the truncation of the TRAF6-interacting domain of XEDAR: a possible novel cause of hypohidrotic ectodermal dysplasia: Figure 1
- A New Advance in Baldness Surgery Using Platelet-Derived Growth Factor
- The new paradigm for androgenetic alopecia and plant-based folk remedies: 5α-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance
- A New Paradigm for the Aging Face
- A new label-free screen for steroid 5α-reductase inhibitors using LC-MS
- The New Keratin Nomenclature
- Discovering New Progenitor Cell Populations through Lineage Tracing and In Vivo Imaging